| Date | Form | Description | Docs | XBRL | Pages |
| 01/10/20 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
110 | |
| 01/09/20 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
4 | |
| 01/09/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
128 |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/04/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/24/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic
Read More...Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application
Read More...OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie
Read More...